Intravitreal triamcinolone for macular edema in Lyme disease

被引：5

作者：

Reibaldi, Michele ^{[1
]}

Faro, Salvatore ^{[1
]}

Motta, Lorenzo ^{[1
]}

Longo, Antonio ^{[1
]}

机构：

[1] Univ Catania, Eye Clin, Catania, Italy

来源：

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2008年 / 246卷 / 03期

关键词：

triamcinolone; macular edema; Lyme disease;

D O I：

10.1007/s00417-007-0740-0

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Background To describe the outcome in a patient with macular edema caused by Lyme disease treated with injection of 4 mg intravitreal triamcinolone. Methods The patient, 2 years after systemic Lyme disease treated with doxycycline for 4 weeks, developed macular edema with serous retinal detachment in one eye (visual acuity: 0.6). After unsuccessful therapy with intravenous ceftriaxone, indomethacin and acetazolamide, 4 mg intravitreal triamcinolone (IVTA) was injected via the pars plana. Results Visual acuity improved to 1.0 and macular thickness recovered over 1 month. No changes were found in intraocular pressure. No recurrence of macular edema was seen after 2 years. Conclusions IVTA can restore visual acuity and reduce macular thickness in macular edema caused by Lyme disease. However, since borreliosis is a systemic disease, previous systemic antibiotic treatment is recommended.

引用

页码：457 / 458

页数：2

共 6 条

[1] INTERMEDIATE UVEITIS AND LYME BORRELIOSIS [J].